Literature DB >> 12035351

Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India.

S Garg1, D R Mathur, D K Garg.   

Abstract

A 5 year retrospective study from June, 1994 to May, 1999 was conducted at Zonal Blood Transfusion Centre, Umaid Hospital and Department of Pathology, Dr. SN Medical College and Associated Group of Hospitals, Jodhpur (Rajastha, Western India. Donors were evaluated for seroprevalence of HIV, HBV, HCV and Syphilis. A Total 46,957 donors were tested, out of which 42,291 (90.1%) were replacement donors and 4666 (9.0%) were voluntary donors. The incidence of HIV was 0.44% in total donors, more in replacement (0.461%) as compare to voluntary (0.279%). The seroprevalence of HBV in total donor was 3.44%. The replacement donors had high incidence (3.52%) as compared to voluntary donors (2.57%). The incidence of HCV seropositivity was 0.285% (5 month data), all were replacement donors (0.328%). The seroprevalence of VDRL in total donor was 0.22%, more in replacement donor (0.239%) as compare to voluntary donors (0.129%). Hence forth, it has been observed that voluntary blood donation is more safe and advocated as compare to replacement donation, as high incidence of HIV, HBV, HCV and Syphilis are observed in replacement donors.

Entities:  

Mesh:

Year:  2001        PMID: 12035351

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  23 in total

Review 1.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 2.  Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis.

Authors:  Ashish Batham; Manoj Anand Gupta; Pallav Rastogi; Shubham Garg; V Sreenivas; Jacob M Puliyel
Journal:  Indian J Pediatr       Date:  2010-01-28       Impact factor: 1.967

3.  Prevalence of transfusion transmitted infections in voluntary and replacement donors.

Authors:  Hilda Fernandes; Prema Fancy D'souza; Pushpa Maria D'souza
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-21       Impact factor: 0.900

Review 4.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

5.  Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study.

Authors:  P Pallavi; C K Ganesh; K Jayashree; G V Manjunath
Journal:  Indian J Hematol Blood Transfus       Date:  2010-12-14       Impact factor: 0.900

Review 6.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

7.  The degree of safety of family replacement donors versus voluntary non-remunerated donors in an Egyptian population: a comparative study.

Authors:  Ibrahim Y Abdel Messih; Mona A Ismail; Abeer A Saad; Mary R Azer
Journal:  Blood Transfus       Date:  2012-11-20       Impact factor: 3.443

8.  Sero-Epidemiological and Behavioural Survey of HIV, HBV and HCV amongst Indian Armed Forces Trainees.

Authors:  M Singh; A Kotwal; R M Gupta; S Adhya; K Chatterjee; J Jayaram
Journal:  Med J Armed Forces India       Date:  2011-07-21

9.  Viral hepatitis: Indian scenario.

Authors:  Sandeep Satsangi; Yogesh K Chawla
Journal:  Med J Armed Forces India       Date:  2016-08-09

10.  Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran.

Authors:  F Keramat; P Eini; M M Majzoobi
Journal:  Iran Red Crescent Med J       Date:  2011-01-01       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.